Searched for
CROFELEMER
- Crofelemer approval a big positive for company: Glenn Saldanha, Glenmark Pharma"There is another $6 million that Salix is likely to pay us for the facility that we are working on for the supplies of Crofelemer."02 Jan, 2013, 12.24 PM IST
- USFDA approves Glenmarkâs anti-diarrheal drug; stock gainsShares of Glenmark Pharma gained momentum following the FDA approval to Salix Pharma for marketing Crofelemer.01 Jan, 2013, 12.43 PM IST
- Glenmark Pharma aims at Rs 5,000 crore revenue during FY13, focus on USGlenmark Pharmaceuticals today said it is aiming for up to 30 per cent growth in revenues this fiscal to touch Rs 5,000 crore.29 Nov, 2012, 09.31 PM IST
- Glenmark Pharmaceuticals gains 7% on Q2 results; brokerages maintain buyThe company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011, Glenmark Pharmaceuticals said in a statemen...31 Oct, 2012, 11.27 AM IST
- Glenmark Pharmaceuticals Q2 net up nearly three fold at Rs 156.75 crGlenmark Pharmaceuticals today said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended Septembe...30 Oct, 2012, 08.54 PM IST
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...28 Dec, 2011, 03.32 PM IST
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDAGlenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.16 Dec, 2011, 08.21 AM IST
- Glenmark gets $15 mn plant upgradation advance from SalixGlenmark Pharmaceuticals on Tuesday said it has received USD 15 million (over Rs 65 crore) from Salix Pharmaceuticals Inc, USA.26 Jul, 2011, 12.43 PM IST
- Glenmark achieves positive results for anti-diarrhoea moleculeGlenmark and Salix have also entered into a commercial supply agreement for Crofelemer active pharmaceutical ingredient.08 Feb, 2011, 03.35 AM IST
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...09 Nov, 2010, 01.58 AM IST
- Glenmark moves closer to HIV drug launchGlenmark Pharmaceuticals has completed the third phase of human trials of Crofelemer, a new drug to treat HIV-related diarrhoea that could ...09 Nov, 2010, 01.51 AM IST
- We continue to remain optimistic about R&D space: Glen SaldanhaGlen Saldanha, Managing Director & CEO, Glenmark Pharmaceuticals speaks to ET Now. Excepts from the interview.04 Feb, 2010, 03.31 PM IST
- Glenmark' Crofelemer enters phase-3 clinical trialsGlenmark Pharmaceuticals on Monday said its Crofelemer, a novel drug in development for multiple indications including HIV-associated diarr...22 Dec, 2008, 02.48 PM IST
- Glenmark Pharmaceutical's Crofelemer enters phase-3 clinical trialsGlenmark Pharmaceuticals, a mid-sized pharma company, on Monday said its Crofelemer, a novel drug in development for multiple indications i...22 Dec, 2008, 02.45 PM IST
- Glenmark will launch Crofelemer in ROW countries by 2010Glenmark Pharmaceuticals Ltd has reported new development that should accelerate the launch of Crofelemer.22 Dec, 2008, 01.19 PM IST
- Glenmark produces anti-diarrhoea ingredientGlenmark Pharmaceuticals Ltd on Friday said it has successfully produced active pharmaceutical ingredient (API), crofelemer, used for chron...17 Nov, 2006, 10.10 PM IST
- Glenmark gets DGCI nod for drug trialGlenmark Pharmaceuticals Ltd today said it has received approval from the Drug Controller General of India (DCGI) to initiate phase II tria...03 Aug, 2006, 02.30 PM IST
Load More- Crofelemer approval a big positive for company: Glenn Saldanha, Glenmark Pharma
